SHORT TERM CALL INFOSYS

SHORT TERM CALL INFY (INFOSYS)

Image Credit : Chart Nexus

Buy Infy Above 1420 With Trading Stoploss Below 1345 Tgt 1445 / 1480 / 1515 / 1536 / 1584 Or Even More.

Tradings Calls For 04.10.2022

TRADING CALLS FOR 04.10.2022

SL : StopLoss

Tgt : Target

Buy Ajanta Pharma Above 1303 With SL Below 1232 Tgt 1332 / 1356 / 1380 / 1409.

Buy Havells Above 1354 SL Below 1315 Tgt 1370 / 1391 / 1406 / 1425+.

Buy Infy Above 1420 SL Below 1376 Tgt 1443 / 1462 / 1485 / 1502.

Buy Ongc Above 135 SL Below 129 Tgt 137.40 / 140.50 / 143 / 145.50

Closing Indices

03 October 2022 

Bse Sensex Closed @ 56788.81 ⬇️ 638.11 Points 

Nse Nifty Closed @ 16887.35 ⬇️ 207.00 Points 

Bank Nifty Closed @ 38029.65 ⬇️ 602.30 Points 

India VIX Closed @ 21.3650 ⬆️ 1.3975 Points

In News

In News

APL Apollo Tubes: The steel tube maker registered the highest quarterly sales volume of 6.02 lakh tonnes in Q2FY23, up 41 percent YoY and growing 42 percent sequentially. The sales volume for the first half of FY23 was 10.25 lakh tonnes compared to 8 lakh tonnes in the same period last year. In the second half of FY23, the sales volume would get further boost from the commissioning and ramp-up of the new Raipur plant, the company said.

Eicher Motors: VE Commercial Vehicles, an unlisted material subsidiary of the company, sold 6,631 vehicles in September 2022, up 9.2 percent from 6,070 units sold in the year-ago period. In the first half of FY23, it registered a 67.6 percent YoY growth in sales at 35,085 vehicles.

Escorts Kubota: Escorts Kubota said its agri machinery segment sold 12,232 tractors in September 2022, registering a growth of 38.7 percent as against 8,816 tractors sold in the same month last year. Domestic tractor sales increased 42.7 percent percent to 11,384 units and export sales grew 0.8 percent to 848 tractors compared to the year-ago period.

Zydus Lifesciences: Zydus Lifesciences has received approval from the United States Food and Drug Administration to market Sildenafil, a high blood pressure drug. It works by relaxing and widening the blood vessels in lungs, which allows the blood to flow more easily. The drug will be manufactured at the group's facility at Baddi, Himachal Pradesh. The drug had annual sales of $65 million in the United States, according to IQVIA data of August 2022.

Poonawalla Fincorp: Care Ratings has upgraded the long-term rating of Poonawalla Fincorp and its subsidiary, Poonawalla Housing Finance (PHFL) to 'AAA' with a stable outlook. This rating is applicable for bank loan facilities, non-convertible debentures, market-linked debentures and subordinated debt.

Spandana Sphoorty Financial: Crisil has removed the company from "watch with developing implications" and reaffirmed rating as 'A' with a stable outlook for bank loan facilities worth Rs 3,500 crore.

Likhitha Infrastructure: The company has received orders worth Rs 177 crore from various oil & gas distribution companies during the quarter ended September 30, 2022. The total outstanding order book of the company as on September 2022 is Rs 1,125 crore.

Dilip Buildcon: The company received a provisional completion certificate for rehabilitation and up-gradation from two to four lane for Varanasi - Dagamagpur section of the National Highway-7 on EPC mode in Uttar Pradesh. With this, the authority declared the project fit for entry into commercial operation on September 29.

Key Results

Today's Key Results 03-Oct-22

ANURAS General  

DHANADACO General  

GETALONG General  

HDIL Audited Results;Quarterly Results

NYKAA Bonus issue 

ROJL General  

SARDAPPR General;Preferential Issue of shares

SKIFL Issue Of Warrants 

Corporate Actions

Today's Corporate Action 3rd Oct Ex Date

JONJUA Bonus issue 4:23 

MAXIMUS Stock  Split From Rs.10/- to Rs.1/-

MOTHERSON Bonus issue 1:2 

SUZLON Right Issue of Equity Shares 

YUG Bonus issue 1:2